Thema
Journal Article
153
Research Support, Non-U.S. Gov't
96
Antineoplastic Agents
49
615
29
che
29
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
25
C07D: Heterocyclic compounds (macromolecular compounds c08)
24
EC 2.7.11.1
22
Protein Kinase Inhibitors
22
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
20
Proto-Oncogene Proteins c-akt
14
Apoptosis
12
Caspases
12
Flavonoids
12
Review
12
EC 2.3.2.27
10
EC 3.4.22.-
10
Enzyme Inhibitors
10
Tumor Suppressor Protein p53
10
Cholinesterase Inhibitors
9
Fluorescent Dyes
9
Imidazoles
9
Leukemia
9
Proto-Oncogene Proteins c-mdm2
9
Ketones
8
Proto-Oncogene Proteins c-bcl-2
8
EC 2.7.10.1
7
Phosphoinositide-3 Kinase Inhibitors
7
Quinoxalines
7
Acetylcholinesterase
6
EC 2.7.11.24
6
EC 3.1.1.7
6
MDM2 protein, human
6
Piperidines
6
Reactive Oxygen Species
6
Vasodilator Agents
6
ATP Binding Cassette Transporter, Subfamily B, Member 1
5
Antineoplastic Agents, Phytogenic
5
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
5
Cell Cycle Proteins
5
I5590ES2QZ
5
Piperazines
5
Proteasome Inhibitors
5
Pyrazoles
5
Receptors, Histamine H3
5
Stilbenes
5
Synthesis
5
TOR Serine-Threonine Kinases
5
Tubulin
5
Tubulin Modulators
5
mehr ...